20.703 articles found

Genetics and Treatment Response in Parkinson's Disease: An Update on Pharmacogenetic Studies.

Politi C, Ciccacci C, Novelli G, Borgiani P.

Neuromolecular Med · 2018-01-05

DOI: 10.1007/s12017-017-8473-7PMID: 29305687

Serotonergic targets for the treatment of L-DOPA-induced dyskinesia.

Lanza K, Bishop C.

J Neural Transm (Vienna) · 2018-01-05

DOI: 10.1007/s00702-017-1837-1PMID: 29305656

Dopaminergic Therapy Increases Go Timeouts in the Go/No-Go Task in Patients with Parkinson's Disease.

Yang XQ, Lauzon B, Seergobin KN, MacDonald PA.

Front Hum Neurosci · 2018-01-04

DOI: 10.3389/fnhum.2017.00642PMID: 29354045

Action Observation Plus Sonification. A Novel Therapeutic Protocol for Parkinson's Patient with Freezing of Gait.

Mezzarobba S, Grassi M, Pellegrini L, Catalan M, Kruger B, Furlanis G, Manganotti P, Bernardis P.

Front Neurol · 2018-01-04

DOI: 10.3389/fneur.2017.00723PMID: 29354092

Effects of ketamine on vocal impairment, gait changes, and anhedonia induced by bilateral 6-OHDA infusion into the substantia nigra pars compacta in rats: Therapeutic implications for Parkinson's disease.

Vecchia DD, Kanazawa LKS, Wendler E, de Almeida Soares Hocayen P, Bruginski E, Campos FR, Stern CAJ, Vital MABF, Miyoshi E, Wöhr M, Schwarting RKW, Andreatini R.

Behav Brain Res · 2018-01-04

DOI: 10.1016/j.bbr.2017.12.041PMID: 29307665

Percutaneous Endoscopic Transgastric Jejunostomy (PEG-J) Tube Placement for Levodopa-Carbidopa Intrajejunal Gel Therapy in the Interventional Radiology Suite: A Long-term Follow-up.

Saddi MV, Sarchioto M, Serra G, Murgia D, Ricchi V, Melis M, Arca R, Carreras P, Sitzia L, Zedda S, Dui G, Rossi R, Ticca A, Melis M, Cossu G.

Mov Disord Clin Pract · 2018-01-03

DOI: 10.1002/mdc3.12569PMID: 30363413

Exenatide and the treatment of Parkinson's disease

Athauda DS.

· 2018-01-01

Evaluation of brain permeability and neuroprotection of novel 3-hydroxy-4-pyridinone bidentate iron chelators for the treatment of Parkinson's disease

Azizi JB.

· 2018-01-01

The role of serotonergic and dopaminergic mechanisms and their interaction in Levodopa-induced dyskinesias

Roussakis AA.

· 2018-01-01

DOI: 10.25560/75512

Application of Monoterpenoids and their Derivatives for Treatment of Neurodegenerative Disorders.

Volcho KP, Laev SS, Ashraf GM, Aliev G, Salakhutdinov NF.

Curr Med Chem · 2018-01-01

DOI: 10.2174/0929867324666170112101837PMID: 28079000

Delta Opioid Receptor and Peptide: A Dynamic Therapy for Stroke and Other Neurological Disorders.

Grant Liska M, Crowley MG, Lippert T, Corey S, Borlongan CV.

Handb Exp Pharmacol · 2018-01-01

DOI: 10.1007/164_2017_7PMID: 28315071

Levodopa in Parkinson's Disease: Current Status and Future Developments.

Tambasco N, Romoli M, Calabresi P.

Curr Neuropharmacol · 2018-01-01

DOI: 10.2174/1570159x15666170510143821PMID: 28494719